SCHEMBL8682252

SCHEMBL8682252

CCOC(=O)c1ccc2nn(CCCNc3ccccn3)c(CCc3ccccc3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.42
▸ ALDH1A1 P00352 6/20 0.42
▸ HPGD P15428 5/20 0.42
▸ CYP2D6 P10635 4/20 0.42
▸ CYP2C9 P11712 4/20 0.42
▸ CYP2C19 P33261 4/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ IDE P14735 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ MAPT P10636 5/20 0.41
▸ ITGB3 P05106 3/20 0.41
▸ ITGAV P06756 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14289015 0.74 ITGB3 (0.60) NPC1RAB9AITGB3ITGAVHTT
SCHEMBL8684069 0.71 RAB9A (0.46) KDM4EALDH1A1HPGDL3MBTL1MAPK1
SCHEMBL8682249 0.70 NPC1 (0.41) ALDH1A1NPC1RAB9AMAPTITGB3
SCHEMBL11562843 0.70 HCAR3 (0.54) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL8683774 0.67 SLC16A3 (0.41) KDM4ERAB9AITGB3ITGAVMEN1
Hydrochloric Acid SCHEMBL8684217 0.66 F2RL3 (0.46) KDM4EALDH1A1MAPK1RAB9AMAPT
SCHEMBL8682759 0.65 ITGB3 (0.40) KDM4EALDH1A1HPGDHSD17B10NPC1
SCHEMBL8683591 0.65 NPC1 (0.43) ALDH1A1CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL16607505 0.65 ALDH1A1 (0.53) ALDH1A1HPGDNPC1RAB9AITGB3
SCHEMBL11954569 0.65 TOP2A (0.57) ALDH1A1HPGDCYP2D6CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760028-A TREATING CANCER METASTASIS, DIABETIC RETINOPATHY, NEOVASCULAR GLAUCOMA, THROMBOSIS, RESTENOSIS, OSTEOPOROSIS, MACULAR DEGENERATION THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-02 — — US disclosed
Send feedback